|I. TERMINATED AGREEMENTS|
Endo Pharmaceuticals Inc. (ENDP)
They ended a deal for the joint development of Propofol IDD-D, an injectable anesthetic and sedative product candidate
Endo backed out of the December 2002 deal, saying the product had a low likelihood of achieving the targeted drug profile; SkyePharma was evaluating its options on the product (4/21)
* Private companies are indicated with an asterisk.
Unless otherwise noted, stock symbols listed are on the Nasdaq market.